[1] Arts L P J, van de Poll-Franse L V, van den Berg S W, et al. Lymphoma InterVEntion (LIVE)-patient-reported outcome feedback and a web-based self-management intervention for patients with lymphoma: study protocol for a randomised controlled trial[J].Trials, 2017, 18(1):199-206.
[2] 马元吉, 陈恩强, 王娟, 等. 原发性肝脏淋巴瘤的研究进展[J]. 世界华人消化杂志, 2010, 18(26):2790 -2793.
[3] 赵翠翠, 王华庆, 钱正子, 等.原发性肝淋巴瘤的临床特点及治疗[J]. 中华肝胆外科杂志, 2013(2):112-115.
[4] Noronha V, Shafi N Q, Obando J A, et al. Primary non-Hodgkin lymphoma of liver[J]. Crit Rev Oncol Hematol, 2005, 53(3):199-207.
[5] Peng Y, Qing A C, Cai J, et al.Lymphoma of the liver: clinico-pathological features of 19 patients[J]. Exp Mol Pathol, 2016, 100(2):276-280.
[6] 王艳丽, 郑玉萍, 苏丽萍, 等. 原发性肝脏淋巴瘤一例诊治讨论[J]. 白血病·淋巴瘤, 2017, 26(2):111-113.
[7] Santos E S, Raez L E, Salvatierra J, et al.Primary hepatic non-hodgkin′s lymphomas:case report and review of the literature[J]. Am J Gastroenterol, 2003, 98(12):2789-2793.
[8] Honda H, Franken E J, Barloon T J, et al. Hepatic lymphoma in cyclosporine-treated transplant recipients:sonographic and ct findings[J]. AJR Am J Roentgenol, 1989, 152(3):501-503.
[9] Andrade X A, Paz L H, Nassar M, et al. Primary liver diffuse large B-cell lymphoma following complete response for hepatitis C infection after direct antiviral therapy[J].Acta Haematol, 2018, 139(2):77-80. |
